Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate: Menactra®
BIOLOGICAL
2 trials
Sponsors
Sanofi Pasteur, a Sanofi Company
Conditions
Meningitis
Meningococcal Infection
Phase 2
Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine
Completed
NCT01442675
Sanofi Pasteur, a Sanofi Company
Meningitis, Meningococcal Infection
Start: 2011-09-30
End: 2012-12-31
Updated: 2014-11-18
Phase 3
Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations
Completed
NCT01359449
Sanofi Pasteur, a Sanofi Company
Meningitis, Meningococcal Infection
Start: 2011-05-31
End: 2012-11-30
Updated: 2016-08-19
Related Papers
Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine
Vaccine
2016-09-16
19 citations
Safety and Immunogenicity of Two Doses of Quadrivalent Meningococcal Conjugate Vaccine or One Dose of Meningococcal Group C Conjugate Vaccine, both Administered Concomitantly with Routine Immunization to 12‐ to 18‐Month‐Old Children
Canadian Journal of Infectious Diseases and Medical Microbiology
2014-01-01
10 citations